MCL1 and B-cell chronic lymphocytic leukemia: Spliceostatin A also increased the MCL-1S:MCL-1L ratio and induced apoptosis cooperatively with ABT-737 in chronic lymphocytic leukemia (CLL) cells, but the pro-apoptotic effect of the drug combination resulted from the accompanying down-regulation of MCL-1L [56].